ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 57 filers reported holding ENTRADA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $22,189,568 | +4.3% | 1,404,403 | -0.1% | 0.00% | 0.0% |
Q2 2023 | $21,283,903 | +592.4% | 1,405,806 | +563.2% | 0.00% | – |
Q1 2023 | $3,073,784 | +20.9% | 211,985 | +12.8% | 0.00% | – |
Q4 2022 | $2,541,679 | +9.3% | 187,994 | +27.4% | 0.00% | – |
Q3 2022 | $2,326,000 | +194.1% | 147,593 | +127.1% | 0.00% | – |
Q2 2022 | $791,000 | -81.1% | 64,999 | -85.4% | 0.00% | – |
Q1 2022 | $4,184,000 | -45.0% | 445,520 | +0.2% | 0.00% | – |
Q4 2021 | $7,609,000 | – | 444,426 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
72 Investment Holdings, LLC | 509,023 | $8,042,563 | 53.88% |
MPM ASSET MANAGEMENT LLC | 4,425,784 | $69,927,387 | 37.45% |
5AM Venture Management, LLC | 4,408,379 | $69,652,388 | 20.04% |
StepStone Group LP | 761,277 | $12,028,177 | 2.68% |
TCG Crossover Management, LLC | 584,955 | $9,242,289 | 1.36% |
Redmile Group, LLC | 1,284,000 | $20,287,200 | 0.96% |
Nan Fung Group Holdings Ltd | 49,082 | $775,496 | 0.63% |
Baker Brothers Advisors | 4,865,819 | $76,879,940 | 0.44% |
Corton Capital Inc. | 10,485 | $165,663 | 0.08% |
CORNERCAP INVESTMENT COUNSEL INC | 13,977 | $220,837 | 0.04% |